Circadian560: Engineering Peak-Blocking Lens Technology for Maximum Melatonin Protection During Evening Artificial Light Exposure
Fuente:
Zenodo
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866902135751311360 |
|---|---|
| author | Dubey, Suraj Choudhary, Monica |
| author_facet | Dubey, Suraj Choudhary, Monica |
| contents | <p><br>This comprehensive technical report examines the neurobiological foundations, clinical evidence, and spectral engineering principles behind<strong> Circadian560 (Patent Pending IN 202521120977)</strong>, a peak-blocking circadian lens technology designed for maximum melatonin protection during evening artificial light exposure. The report covers: (i) <em>molecular architecture of circadian photoreception from melanopsin phototransduction through the retinohypothalamic tract to SCN clock gene regulation;</em> (ii) melatonin biosynthetic pathway and multi-system physiological functions beyond sleep; (iii) quantitative dose-response relationship showing 85% melatonin suppression from ordinary room lighting (Gooley et al., 2011); (iv) systematic review of five published clinical studies supporting amber lens interventions (Burkhart 2009, van der Lely 2015, Esaki 2016, Shechter 2018, Sasseville 2006); (v) critical analysis of generic amber lens limitations; and (vi) engineering rationale for the 560nm blocking boundary based on the melanopsin action spectrum. Spectrometer-verified data confirms 99.95% blocking at 480nm melanopsin peak and 99.87% across 380-500nm. Twenty-five peer-reviewed references cited.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19594265 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Circadian560: Engineering Peak-Blocking Lens Technology for Maximum Melatonin Protection During Evening Artificial Light Exposure Dubey, Suraj Choudhary, Monica Circadian560 Sleep Disorders, Circadian Rhythm circadian rhythm Melatonin melanopsin blue light blocking amber lenses DLMO suprachiasmatic nucleus <p><br>This comprehensive technical report examines the neurobiological foundations, clinical evidence, and spectral engineering principles behind<strong> Circadian560 (Patent Pending IN 202521120977)</strong>, a peak-blocking circadian lens technology designed for maximum melatonin protection during evening artificial light exposure. The report covers: (i) <em>molecular architecture of circadian photoreception from melanopsin phototransduction through the retinohypothalamic tract to SCN clock gene regulation;</em> (ii) melatonin biosynthetic pathway and multi-system physiological functions beyond sleep; (iii) quantitative dose-response relationship showing 85% melatonin suppression from ordinary room lighting (Gooley et al., 2011); (iv) systematic review of five published clinical studies supporting amber lens interventions (Burkhart 2009, van der Lely 2015, Esaki 2016, Shechter 2018, Sasseville 2006); (v) critical analysis of generic amber lens limitations; and (vi) engineering rationale for the 560nm blocking boundary based on the melanopsin action spectrum. Spectrometer-verified data confirms 99.95% blocking at 480nm melanopsin peak and 99.87% across 380-500nm. Twenty-five peer-reviewed references cited.</p> |
| title | Circadian560: Engineering Peak-Blocking Lens Technology for Maximum Melatonin Protection During Evening Artificial Light Exposure |
| topic | Circadian560 Sleep Disorders, Circadian Rhythm circadian rhythm Melatonin melanopsin blue light blocking amber lenses DLMO suprachiasmatic nucleus |
| url | https://doi.org/10.5281/zenodo.19594265 |